no credit card required  No credit card. No commitment.
 5000 plus G2 reviews  5000+ G2 reviews
Company logo

Claritas Pharmaceuticals

Claritas Pharmaceuticals


Claritas Pharmaceuticals' financial review

Employees

3

Total Funding

930K

Last Funding Round

930K


Claritas Pharmaceuticals information

Claritas Pharmaceuticals is developing R-107, a nitric oxide releasing molecule designed to treat vaccine-resistant COVID-19 infection.Nitric oxide is the immune system's first line of defense against viral infection. When a viral threat is present, white blood cells migrate to the area of infection and release a burst of nitric oxide that crosses into the infected cell to inactivate the virus. In...
Claritas Pharmaceuticals is developing R-107, a nitric oxide releasing molecule designed to treat vaccine-resistant COVID-19 infection.Nitric oxide is the immune system's first line of defense against viral infection. When a viral threat is present, white blood cells migrate to the area of infection and release a burst of nitric oxide that crosses into the infected cell to inactivate the virus. In COVID-19 infections, natural nitric oxide levels may not be sufficient to eradicate the virus. R-107 augments the body's natural release of nitric oxide to strengthen the body's ability to eliminate the virus. Unlike vaccine therapy, which may prove ineffective against new mutations, R-107 is engineered to treat all current and future mutant forms of COVID-19.Our scientific team has built a reputation for global leadership in basic science, drug development, and clinical medicine. Our expertise and professional network enable us to create groundbreaking opportunities that tackle drug development challenges.Claritas Pharmaceuticals is headquartered in San Francisco, CA. The Company has leased recently renovated 8,500 square feet of laboratory, office, and archival space in Beverly, Massachusetts, fully-equipped with state-of-the-art systems to carry out analytical, bioanalytical, and synthetic chemistry activities.

Claritas Pharmaceuticals industries

Pharmaceuticals
Pharmaceutical manufacturing
Medical

Claritas Pharmaceuticals' financial review

Employees

3

Total Funding

930K

Last Funding Round

930K

Technologies

Frameworks and Programming Languages
Other
Other
Frameworks and Programming Languages
Frameworks and Programming Languages

Prospect on LinkedIn

Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download ExtensionRepresents linkedin prospector
Browse Apollo's Directories

Why our clients choose Apollo

“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Image of Erik Straub

Erik Straub

Head of Product, Kickfurther

“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Image of Michael Transon

Michael Transon

CEO, Victorious

Apollo gives you all the company insights you need

Free to get started, easy to add your whole sales team, commit to monthly or annual plans. We make it easy to get started.